Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04665999 · ClinicalTrials.gov registry record

Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes

A clinical trial of Type 1 Diabetes Mellitus, sponsored by University of Virginia.

Completed
Registry status
37
Enrollment target
1
Study location

NCT04665999 is a study of Type 1 Diabetes Mellitus that has completed, run by University of Virginia. The registered enrollment target is 37 participants, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04665999, a study of Type 1 Diabetes Mellitus, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
37 participants
Enrollment target
1
Study location

Study Summary

This is an observational study. Forty females with type 1 diabetes (age 18-40) using a continuous glucose monitor and an insulin pump will be enrolled for a 3-month data collection. Study participants will include free-cycling females and females following oral contraceptive therapy. All study appointments may be completed virtually.

Conditions Studied

Interventions

  • DEVICE Continuous Glucose Monitor

Study Locations (1)

Virginia

  • University of Virginia Center for Diabetes Technology - Charlottesville

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2021-01-15
Est. Completion 2022-03-10

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04665999

The ClinicalTrials.gov registry entry for NCT04665999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (74% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor is the first listed.

NCT04665999 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04665999 about?

NCT04665999 is a clinical study titled "Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes". This is an observational study. Forty females with type 1 diabetes (age 18-40) using a continuous glucose monitor and an insulin pump will be enrolled for a 3-month data collection. Study participants will include free-cycling females and females following oral contraceptive therapy. All study appoi...

What is the current status of trial NCT04665999?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2021-01-15. Estimated completion is 2022-03-10.

What conditions does trial NCT04665999 study?

This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.

What interventions are being tested in trial NCT04665999?

The interventions under investigation include: Continuous Glucose Monitor (DEVICE).

Who is sponsoring clinical trial NCT04665999?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04665999 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.